Sonnet BioTherapeutics (SONN) Stock Chart & Stock Price History $3.38 -0.17 (-4.79%) Closing price 04:00 PM EasternExtended Trading$3.62 +0.25 (+7.25%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sonnet BioTherapeutics Stock Price Performance The Sonnet BioTherapeutics (SONN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 41.92%, with a year-to-date return of 131.51%. In the past month, the stock has decreased 16.54%, reflecting recent market activity. As of the latest close, Sonnet BioTherapeutics traded at $3.55 with a market cap of $23.96 million and volume of 267,394 shares. Five years ago, the stock traded at a split-adjusted price of $6,677.44, representing a 99.95% decrease over that period. At the time, it had a market cap of $43.12 million and a volume of 9,406 shares. Receive SONN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.59%1 Month Performance-16.54%3 Month Performance+192.64%Year-To-Date Performance+131.51%1 Year Performance-41.92%5 Year Performance-99.95% SONN Stock Chart for Thursday, August, 28, 2025 SONN Chart by TradingView Sonnet BioTherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$3.55$3.38-4.79%$3.66$3.34218,563 shs$22.82 million08/27/2025$3.61$3.55-1.66%$3.80$3.53267,394 shs$23.96 million08/26/2025$3.59$3.61+0.56%$3.77$3.47331,056 shs$24.38 million08/25/2025$3.47$3.59+3.46%$3.90$3.47645,547 shs$24.23 million08/22/2025$3.38$3.47+2.66%$3.52$3.24274,504 shs$11 million08/21/2025$3.22$3.38+4.97%$3.61$3.22299,422 shs$10.72 million08/20/2025$3.19$3.22+0.94%$3.31$2.99198,507 shs$10.20 million08/19/2025$3.35$3.19-4.78%$3.48$3.12348,024 shs$10.11 million08/18/2025$3.54$3.35-5.37%$3.52$3.35194,281 shs$10.62 million08/15/2025$3.76$3.54-5.85%$3.76$3.32604,699 shs$11.22 million Get the Latest News and Ratings for SONN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$3.95$3.76-4.81%$4.29$3.491.44 million shs$11.92 million08/13/2025$2.99$3.95+32.11%$4.05$3.052.87 million shs$12.51 million08/12/2025$3.07$2.99-2.61%$3.17$2.80357,712 shs$9.48 million08/11/2025$3.22$3.07-4.66%$3.59$3.01832,614 shs$9.73 million08/08/2025$2.88$3.22+11.81%$3.36$2.75751,907 shs$10.21 million08/07/2025$2.98$2.88-3.36%$3.18$2.83400,796 shs$9.12 million08/06/2025$2.65$2.98+12.45%$3.19$2.48794,842 shs$9.45 million08/05/2025$2.81$2.65-5.69%$2.94$2.58524,475 shs$8.40 million08/04/2025$2.81$2.81$2.96$2.61875,314 shs$8.90 million08/01/2025$3.32$2.81-15.36%$3.20$2.711.05 million shs$8.90 million07/31/2025$3.22$3.32+3.11%$3.50$3.17286,409 shs$10.52 million07/30/2025$3.26$3.22-1.23%$3.66$3.21440,075 shs$10.21 million07/29/2025$4.05$3.26-19.51%$3.92$3.101.12 million shs$10.32 million07/28/2025$3.99$4.05+1.50%$4.38$3.98565,220 shs$12.84 million Related Companies Clene Stock Chart Renovaro Stock Chart Exicure Stock Chart Sol-Gel Technologies Stock Chart PepGen Stock Chart Senti Biosciences Stock Chart Hyperion DeFi Stock Chart Eagle Pharmaceuticals Stock Chart CalciMedica Stock Chart LAVA Therapeutics Stock Chart Receive SONN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SONN) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access